pIRES I and pIRES II Vaccination Induces the Activation of Antigen-specific CD8+ T Cells and Simultaneous Protective Responses against Gag-expressing Vaccinia Virus and Tumor Cells Expressing HPV-16 Antigens. Here, CD8A is linked to neoplasm.